SU 5416 semaxanib

Details:

Semaxanib, also known as SU5416, is a quinolone derivative with potential antineoplastic activity. Semaxanib reversibly inhibits ATP binding to the tyrosine kinase domain of vascular endothelial growth factor receptor 2 (VEGFR2), which may inhibit VEGF-stimulated endothelial cell migration and proliferation and reduce the tumor microvasculature. This agent also inhibits the phosphorylation of the stem cell factor receptor tyrosine kinase c-kit, often expressed in acute myelogenous leukemia cells.

Shipping Condition:

Kailiqi Biopharma is a professional manufacturer specialized in the production and distribution of active pharmaceutical ingredients and intermediates.. We develop produce and distribute high quality pharmaceuticals, intermediates, special chemicals and OLED materials & OLED intermediates and other fine chemicals. Kailiqi Biopharmaconsists a team of professional analytical department complete QC&QA under strict SOPs, experienced sale and after-sale service, efficient logistic support.
We are good at technology：
1.High pressure hydrogenation
2. Low temperature reactions (-90°C)
3. Chiral compounds by asymmetric synthesis (either chiral auxiliaries or catalysts)
4. Small molecule biologics (e.g. non-natural amino acids, fluorinated amino acids)
5. Green reactions (ionic liquids/fluorous chemistry)

We could give you:
1. Best quality in your requirement
2. Competitive price in China market
3. Mature Technical support
4. Professional logistic support

All we want is win-win business. Send us your inquiries, you will get it!